Schedule 13G ownership disclosure
NEKTAR THERAPEUTICS
Security class unavailable · CUSIP: 640268108
Event date: 2017-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 14,604,569
- Percent of class
- 9.2700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000728889-18-000211
- Form type
- SC 13G
- Filer
- NEKTAR THERAPEUTICS
- CIK
- CIK 906709
- Filed
- Feb 06, 2018
- Reporting period
- Dec 31, 2017
- Description
- Schedule 13G beneficial ownership